Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Modeling Human Cancer-induced Cachexia.

Talbert EE, Cuitiño MC, Ladner KJ, Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo B, Weisleder N, Reiser PJ, Webb A, Timmers CD, Eiferman DS, Evans DC, Dillhoff ME, Schmidt CR, Guttridge DC.

Cell Rep. 2019 Aug 6;28(6):1612-1622.e4. doi: 10.1016/j.celrep.2019.07.016.

2.

Endoscopic Ultrasound-Guided Confocal Laser Endomicroscopy Increases Accuracy of Differentiation of Pancreatic Cystic Lesions.

Krishna SG, Hart PA, Malli A, Kruger A, McCarthy ST, El-Dika S, Walker JP, Dillhoff ME, Manilchuk A, Schmidt CR, Pawlik TM, Porter K, Arnold CA, Cruz-Monserrate Z, Conwell DL.

Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30648-2. doi: 10.1016/j.cgh.2019.06.010. [Epub ahead of print]

PMID:
31220640
3.

Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV.

JAMA Surg. 2019 May 29. doi: 10.1001/jamasurg.2019.1170. [Epub ahead of print]

PMID:
31141112
4.

Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group.

Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Schmidt CR, Maithel SK, Pawlik TM; United States Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Aug;120(2):231-240. doi: 10.1002/jso.25481. Epub 2019 Apr 18.

PMID:
31001868
5.

Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group.

Dave A, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Ronnekleiv-Kelly S, Rendell VR, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems M, Maithel SK, Pawlik TM, Schmidt CR, Dillhoff ME.

J Gastrointest Surg. 2019 Apr 2. doi: 10.1007/s11605-019-04120-4. [Epub ahead of print]

PMID:
30941685
6.

Compliance with preoperative care measures reduces surgical site infection after colorectal operation.

Guzman-Pruneda FA, Husain SG, Jones CD, Beal EW, Porter E, Grove M, Moffatt-Bruce S, Schmidt CR.

J Surg Oncol. 2019 Mar;119(4):497-502. doi: 10.1002/jso.25346. Epub 2018 Dec 24.

PMID:
30582613
7.

Perioperative use of blood products is associated with risk of morbidity and mortality after surgery.

Beal EW, Bagante F, Paredes A, Akgul O, Merath K, Cua S, Dillhoff ME, Schmidt CR, Abel E, Scrape S, Ejaz A, Pawlik TM.

Am J Surg. 2019 Jul;218(1):62-70. doi: 10.1016/j.amjsurg.2018.11.015. Epub 2018 Nov 27.

PMID:
30509453
8.

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases.

McDermott SM, Saunders ND, Schneider EB, Strosberg D, Onesti J, Dillhoff M, Schmidt CR, Shirley LA.

J Surg Res. 2018 Dec;232:369-375. doi: 10.1016/j.jss.2018.06.058. Epub 2018 Jul 18.

PMID:
30463743
9.

Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.

Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola-Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM.

Surgery. 2019 Mar;165(3):657-663. doi: 10.1016/j.surg.2018.09.008. Epub 2018 Oct 28.

PMID:
30377003
10.

Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.

Chakedis J, Beal EW, Sun S, Galo J, Chafitz A, Davidson G, Reardon J, Dillhoff M, Pawlik TM, Abdel-Misih S, Bloomston M, Schmidt CR.

J Surg Oncol. 2018 Dec;118(7):1065-1073. doi: 10.1002/jso.25249.

PMID:
30376157
11.

Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.

Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola-Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M.

J Gastrointest Surg. 2019 Jan;23(1):122-134. doi: 10.1007/s11605-018-3986-4. Epub 2018 Oct 17.

PMID:
30334178
12.

Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.

Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM.

Surgery. 2019 Mar;165(3):548-556. doi: 10.1016/j.surg.2018.08.015. Epub 2018 Sep 29.

PMID:
30278986
13.

Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors.

Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA.

Ann Surg Oncol. 2018 Nov;25(12):3613-3620. doi: 10.1245/s10434-018-6741-x. Epub 2018 Sep 4.

PMID:
30182331
14.

What is the Incidence of Malignancy in Resected IPMN? An Analysis of Over 100 U.S. Institutions in a Single Year.

Schmidt CR, Cloyd J.

Ann Surg Oncol. 2018 Jul;25(7):1797-1798. doi: 10.1245/s10434-018-6478-6. Epub 2018 Apr 19. No abstract available.

PMID:
29675763
15.

Accuracy of the ACS NSQIP Online Risk Calculator Depends on How You Look at It: Results from the United States Gastric Cancer Collaborative.

Beal EW, Saunders ND, Kearney JF, Lyon E, Wei L, Squires MH, Jin LX, Worhunsky DJ, Votanopoulos KI, Ejaz A, Poultsides G, Fields RC, Swords D, Acher AW, Weber SM, Maithel SK, Pawlik T, Schmidt CR.

Am Surg. 2018 Mar 1;84(3):358-364.

PMID:
29559049
16.

Surgical Treatment of Metastatic Colorectal Cancer.

Chakedis J, Schmidt CR.

Surg Oncol Clin N Am. 2018 Apr;27(2):377-399. doi: 10.1016/j.soc.2017.11.010. Epub 2017 Dec 15. Review.

PMID:
29496096
17.

Development and prospective validation of a model estimating risk of readmission in cancer patients.

Schmidt CR, Hefner J, McAlearney AS, Graham L, Johnson K, Moffatt-Bruce S, Huerta T, Pawlik TM, White S.

J Surg Oncol. 2018 May;117(6):1113-1118. doi: 10.1002/jso.24968. Epub 2018 Feb 26.

PMID:
29484659
18.

Identification of patients at high risk for post-discharge venous thromboembolism after hepato-pancreato-biliary surgery: which patients benefit from extended thromboprophylaxis?

Beal EW, Tumin D, Chakedis J, Porter E, Moris D, Zhang XF, Abdel-Misih S, Dillhoff M, Manilchuk A, Cloyd J, Schmidt CR, Pawlik TM.

HPB (Oxford). 2018 Jul;20(7):621-630. doi: 10.1016/j.hpb.2018.01.004. Epub 2018 Feb 19.

19.

The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.

Zhang XF, Squires MH 3rd, Bagante F, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Weiss M, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM.

Ann Surg Oncol. 2018 May;25(5):1140-1149. doi: 10.1245/s10434-018-6382-0. Epub 2018 Feb 22.

PMID:
29470820
20.

Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group.

Merath K, Bagante F, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM.

J Surg Oncol. 2018 Apr;117(5):868-878. doi: 10.1002/jso.24985. Epub 2018 Feb 15.

21.

Exosomes in Pancreatic Cancer: from Early Detection to Treatment.

Armstrong EA, Beal EW, Chakedis J, Paredes AZ, Moris D, Pawlik TM, Schmidt CR, Dillhoff ME.

J Gastrointest Surg. 2018 Apr;22(4):737-750. doi: 10.1007/s11605-018-3693-1. Epub 2018 Feb 8. Review.

PMID:
29423813
22.

Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.

Zhang XF, Beal EW, Chakedis J, Chen Q, Lv Y, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Buettner S, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM.

World J Surg. 2018 Sep;42(9):2919-2929. doi: 10.1007/s00268-018-4530-0.

PMID:
29404753
23.

Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.

Talbert EE, Lewis HL, Farren MR, Ramsey ML, Chakedis JM, Rajasekera P, Haverick E, Sarna A, Bloomston M, Pawlik TM, Zimmers TA, Lesinski GB, Hart PA, Dillhoff ME, Schmidt CR, Guttridge DC.

J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):358-368. doi: 10.1002/jcsm.12251. Epub 2018 Jan 7.

24.

The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium.

Bhutiani N, Scoggins CR, McMasters KM, Ethun CG, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, Fields RC, Idrees K, Hatzaras I, Shen P, Maithel SK, Martin RCG 2nd.

Surgery. 2018 Apr;163(4):726-731. doi: 10.1016/j.surg.2017.10.028. Epub 2018 Jan 3.

PMID:
29306541
25.

Which Patients Require Extended Thromboprophylaxis After Colectomy? Modeling Risk and Assessing Indications for Post-discharge Pharmacoprophylaxis.

Beal EW, Tumin D, Chakedis J, Porter E, Moris D, Zhang XF, Arnold M, Harzman A, Husain S, Schmidt CR, Pawlik TM.

World J Surg. 2018 Jul;42(7):2242-2251. doi: 10.1007/s00268-017-4447-z.

PMID:
29302726
26.

Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.

Krasnick BA, Jin LX, Davidson JT 4th, Sanford DE, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Hawkins WG, Chapman WC, Doyle MBM, Weber SM, Strasberg SM, Salem A, Martin RCG, Isom CA, Scoggins C, Schmidt CR, Shen P, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.

J Surg Oncol. 2018 Mar;117(3):363-371. doi: 10.1002/jso.24836. Epub 2017 Dec 28.

27.

Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.

Owen DH, Alexander AJ, Konda B, Wei L, Hemminger JA, Schmidt CR, Abdel-Misih SRZ, Dillhoff ME, Sipos JA, Kirschner LS, Shah MH.

Oncotarget. 2017 Oct 24;8(61):104046-104056. doi: 10.18632/oncotarget.22001. eCollection 2017 Nov 28.

28.

Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.

Zhang XF, Beal EW, Merath K, Ethun CG, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Weiss M, Scoggins C, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR, Pawlik TM.

J Surg Oncol. 2018 May;117(6):1267-1277. doi: 10.1002/jso.24945. Epub 2017 Dec 4.

PMID:
29205351
29.

Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma.

Lewis HL, Chakedis JM, Talbert E, Haverick E, Rajasekera P, Hart P, Bloomston M, Dillhoff M, Pawlik TM, Guttridge D, Schmidt CR.

J Surg Oncol. 2018 May;117(6):1260-1266. doi: 10.1002/jso.24940. Epub 2017 Dec 4.

PMID:
29205349
30.

Variation in markup of general surgical procedures by hospital market concentration.

Cerullo M, Chen SY, Dillhoff M, Schmidt CR, Canner JK, Pawlik TM.

Am J Surg. 2018 Apr;215(4):549-556. doi: 10.1016/j.amjsurg.2017.10.028. Epub 2017 Oct 23.

PMID:
29096872
31.

Erratum: DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.

Brocks D, Schmidt CR, Daskalakis M, Jang HS, Shah NM, Li D, Li J, Zhang B, Hou Y, Laudato S, Lipka DB, Schott J, Bierhoff H, Assenov Y, Helf M, Ressnerova A, Islam MS, Lindroth AM, Haas S, Essers M, Imbusch CD, Brors B, Oehme I, Witt O, Lübbert M, Mallm JP, Rippe K, Will R, Weichenhan D, Stoecklin G, Gerhäuser C, Oakes CC, Wang T, Plass C.

Nat Genet. 2017 Oct 27;49(11):1661. doi: 10.1038/ng1117-1661c.

PMID:
29074949
32.

The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing.

Lim J, Park JH, Baude A, Yoo Y, Lee YK, Schmidt CR, Park JB, Fellenberg J, Zustin J, Haller F, Krücken I, Kang HG, Park YJ, Plass C, Lindroth AM.

Sci Rep. 2017 Oct 18;7(1):13459. doi: 10.1038/s41598-017-13887-y.

33.

Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.

Nemer L, Krishna SG, Shah ZK, Conwell DL, Cruz-Monserrate Z, Dillhoff M, Guttridge DC, Hinton A, Manilchuk A, Pawlik TM, Schmidt CR, Talbert EE, Bekaii-Saab T, Hart PA.

Pancreas. 2017 Oct;46(9):1152-1157. doi: 10.1097/MPA.0000000000000898.

34.

NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development.

Ratnam NM, Peterson JM, Talbert EE, Ladner KJ, Rajasekera PV, Schmidt CR, Dillhoff ME, Swanson BJ, Haverick E, Kladney RD, Williams TM, Leone GW, Wang DJ, Guttridge DC.

J Clin Invest. 2017 Oct 2;127(10):3796-3809. doi: 10.1172/JCI91561. Epub 2017 Sep 11.

35.

Introduction to the JSO enhanced recover after surgery seminar edition.

Schmidt CR.

J Surg Oncol. 2017 Oct;116(5):569. doi: 10.1002/jso.24803. Epub 2017 Sep 10. No abstract available.

PMID:
28891240
36.

Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium.

Beal EW, Lyon E, Kearney J, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, Weber SM, Tran TB, Poultsides G, Shenoy R, Hatzaras I, Krasnick B, Fields RC, Buttner S, Scoggins CR, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Pawlik TM, Schmidt CR.

HPB (Oxford). 2017 Dec;19(12):1104-1111. doi: 10.1016/j.hpb.2017.08.009. Epub 2017 Sep 7.

37.

Enhanced recovery after surgery-Summary recommendations.

Schmidt CR.

J Surg Oncol. 2017 Oct;116(5):638. doi: 10.1002/jso.24802. Epub 2017 Sep 5. No abstract available.

PMID:
28873506
38.

Favorable and Durable Response to Pazopanib in Metastatic Refractory Paraganglioma.

Patel S, Owen D, Schmidt CR, Kirschner LS, Phay J, Shirley L, Dillhoff M, Brock P, Espinosa A, Shah MH, Konda B.

J Oncol Pract. 2017 Dec;13(12):840-842. doi: 10.1200/JOP.2017.024984. Epub 2017 Aug 29. No abstract available.

PMID:
28850312
39.

A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage.

Van Buren G 2nd, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, Morgan KA, Hughes SJ, Karanicolas PJ, Allendorf JD, Vollmer CM Jr, Ly Q, Brown KM, Velanovich V, Winter JM, McElhany AL, Muscarella P 2nd, Schmidt CM, House MG, Dixon E, Dillhoff ME, Trevino JG, Hallet J, Coburn NSG, Nakeeb A, Behrns KE, Sasson AR, Ceppa EP, Abdel-Misih SRZ, Riall TS, Silberfein EJ, Ellison EC, Adams DB, Hsu C, Tran Cao HS, Mohammed S, Villafañe-Ferriol N, Barakat O, Massarweh NN, Chai C, Mendez-Reyes JE, Fang A, Jo E, Mo Q, Fisher WE.

Ann Surg. 2017 Sep;266(3):421-431. doi: 10.1097/SLA.0000000000002375.

PMID:
28692468
40.

Current Management of Perihilar Cholangiocarcinoma and Future Perspectives.

Lewis HL, Rahnemai-Azar AA, Dillhoff M, Schmidt CR, Pawlik TM.

Chirurgia (Bucur). 2017 May-Jun;112(3):193-207. doi: 10.21614/chirurgia.112.3.193. Review.

41.

Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer.

Gani F, Johnston FM, Nelson-Williams H, Cerullo M, Dillhoff ME, Schmidt CR, Pawlik TM.

J Gastrointest Surg. 2017 Sep;21(9):1411-1419. doi: 10.1007/s11605-017-3479-x. Epub 2017 Jun 29.

PMID:
28664254
42.

DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.

Brocks D, Schmidt CR, Daskalakis M, Jang HS, Shah NM, Li D, Li J, Zhang B, Hou Y, Laudato S, Lipka DB, Schott J, Bierhoff H, Assenov Y, Helf M, Ressnerova A, Islam MS, Lindroth AM, Haas S, Essers M, Imbusch CD, Brors B, Oehme I, Witt O, Lübbert M, Mallm JP, Rippe K, Will R, Weichenhan D, Stoecklin G, Gerhäuser C, Oakes CC, Wang T, Plass C.

Nat Genet. 2017 Jul;49(7):1052-1060. doi: 10.1038/ng.3889. Epub 2017 Jun 12. Erratum in: Nat Genet. 2017 Oct 27;49(11):1661.

43.

Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy.

Ecker BL, McMillan MT, Asbun HJ, Ball CG, Bassi C, Beane JD, Behrman SW, Berger AC, Dickson EJ, Bloomston M, Callery MP, Christein JD, Dixon E, Drebin JA, Castillo CF, Fisher WE, Fong ZV, Haverick E, Hollis RH, House MG, Hughes SJ, Jamieson NB, Javed AA, Kent TS, Kowalsky SJ, Kunstman JW, Malleo G, Poruk KE, Salem RR, Schmidt CR, Soares K, Stauffer JA, Valero V, Velu LKP, Watkins AA, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2018 Apr;267(4):608-616. doi: 10.1097/SLA.0000000000002327.

PMID:
28594741
44.

Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.

Kim Y, Squires MH, Poultsides GA, Fields RC, Weber SM, Votanopoulos KI, Kooby DA, Worhunsky DJ, Jin LX, Hawkins WG, Acher AW, Cho CS, Saunders N, Levine EA, Schmidt CR, Maithel SK, Pawlik TM.

Surgery. 2017 Aug;162(2):285-294. doi: 10.1016/j.surg.2017.03.023. Epub 2017 May 31.

45.

In vivo and ex vivo confocal endomicroscopy of pancreatic cystic lesions: A prospective study.

Krishna SG, Modi RM, Kamboj AK, Swanson BJ, Hart PA, Dillhoff ME, Manilchuk A, Schmidt CR, Conwell DL.

World J Gastroenterol. 2017 May 14;23(18):3338-3348. doi: 10.3748/wjg.v23.i18.3338.

46.

Interval Magnetic Resonance Imaging: an Alternative to Guidelines for Indeterminate Nodules Discovered in the Cirrhotic Liver.

Beal EW, Kearney JF, Chakedis JM, James Hanje A, Conteh LF, Black SM, Washburn K, Dittmar KM, Pawlik TM, Dillhoff MR, Schmidt CR.

J Gastrointest Surg. 2017 Sep;21(9):1463-1470. doi: 10.1007/s11605-017-3454-6. Epub 2017 May 26.

PMID:
28550393
47.

Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.

Beal EW, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, Weber SM, Tran T, Poultsides G, Son AY, Hatzaras I, Jin L, Fields RC, Buettner S, Pawlik TM, Scoggins C, Martin RC, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Schmidt CR.

HPB (Oxford). 2016 Nov;18(11):950-957. doi: 10.1016/j.hpb.2016.08.006. Epub 2016 Sep 24.

48.

Revisiting von Restorff's early isolation effect.

Schmidt SR, Schmidt CR.

Mem Cognit. 2017 Feb;45(2):194-207. doi: 10.3758/s13421-016-0651-6.

PMID:
27631791
49.

E2f8 mediates tumor suppression in postnatal liver development.

Kent LN, Rakijas JB, Pandit SK, Westendorp B, Chen HZ, Huntington JT, Tang X, Bae S, Srivastava A, Senapati S, Koivisto C, Martin CK, Cuitino MC, Perez M, Clouse JM, Chokshi V, Shinde N, Kladney R, Sun D, Perez-Castro A, Matondo RB, Nantasanti S, Mokry M, Huang K, Machiraju R, Fernandez S, Rosol TJ, Coppola V, Pohar KS, Pipas JM, Schmidt CR, de Bruin A, Leone G.

J Clin Invest. 2016 Aug 1;126(8):2955-69. doi: 10.1172/JCI85506. Epub 2016 Jul 25.

50.

Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?

Kitano M, Davidson GW, Shirley LA, Schmidt CR, Guy GE, Khabiri H, Dowell JD, Shah MH, Bloomston M.

Ann Surg Oncol. 2016 Nov;23(12):4008-4015. Epub 2016 Jul 8.

PMID:
27393568

Supplemental Content

Loading ...
Support Center